Micromet to Present at The 8th Annual BIO Investor Forum Conference on Octobe... ( BETHESDA Md. Oct. 21 /- Micromet Inc....)

Micromet to Present at The 8th Annual BIO Investor Forum Conference on October 29, 2009

Date:10/21/2009

BETHESDA, Md., Oct. 21 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI), a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, today announced that its Senior Vice President and Chief Financial Officer, Barclay Phillips, will present at The 8th Annual BIO Investor Forum on October 29, 2009 in San Francisco. A simultaneous webcast of the event will be available on the company's website at www.micromet-inc.com.

    Forum:      The 8th Annual BIO Investor Forum

    Date:       Thursday, October 29, 2009

    Time:       9:30 am U.S. Pacific Time

    Place:      Palace Hotel
                San Francisco, California

    Webcast:    www.micromet-inc.com

About Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® antibody platform, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet's preclinical product pipeline includes several novel BiTE antibodies generated with its proprietary BiTE antibody platform technology. Micromet's collaboration partners include Bayer Schering Pharma, Merck Serono, MedImmune and Nycomed.

Forward-Looking Statements

This release contains certain forward-looking statements that involve risks and uncertainties that could cause actual results to be materially different from historical results or from any future results expressed or implied by such forward-looking statements. These forward-looking s
'/>"/>

SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Micromets Blinatumomab Achieves Primary Endpoint in Phase 2 Study with Acute Lymphoblastic Leukemia Patients
2. Micromet Presents Update on Blinatumomabs Response Rate and Duration in a Phase 1 Study in Non-Hodgkins Lymphoma Patients
3. Micromet Presents Update on BiTE Antibody Pipeline and Reviews Key AACR Presentations at R&D Day
4. Micromet Presents Preclinical Data Showing Activity of Erbitux and Vectibix Based BiTE Antibodies against KRAS- and BRAF-mutated Human Colorectal Cancer Cells
5. Micromet Receives Milestone Payment for Filing of the First Clinical Trial Application for MT203
6. Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients
7. Micromet Key Events for 2009
8. Micromet Expands Committed Equity Financing Facility to $75 Million
9. Micromet Presents Data at the 23rd Annual Meeting of the International Society for Biological Therapy of Cancer on the Activity of Human Antibody Adecatumumab against KRAS-mutated Colon Cancer Cells
10. Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy
11. Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE

Post Your Comments:

(Date:12/16/2009)... Mass., Dec. 16 Boston Scientific Corporation (NYSE: ... Board of Directors has elected Nelda Connors as a ... of the Electrical and Metal Products division of Tyco ... Eaton Corporation, holding several positions in operations and general ... in a number of executive and management capacities with ...

(Date:12/16/2009)... Pa., Dec. 16 Siemens ... financing solutions to ... and meet deadlines defined within the HITECH ... Act (ARRA). Featuring zero-percent interest ... organizations to defer up-front payments associated with ...

(Date:12/16/2009)... Dec. 16 BioSpecifics Technologies Corp. (Nasdaq: ... in class collagenase-based products, today announced top-line efficacy ... trial of XIAFLEX(TM) for the treatment of Peyronie,s ... of inelastic collagen on the shaft of the ... sexual intercourse difficult or impossible in advanced cases. ...

[0] Boston Scientific Announces Election of Nelda Connors to Its Board of Directors [0] Siemens Unveils Flexible Financing Solutions to Help Providers Achieve Meaningful Use [0] BioSpecifics Technologies Corp. Announces Top-Line Phase 2b Results for XIAFLEX(TM) for Treatment of Peyronie's Disease

... 2008, TARRYTOWN, N.Y., Oct. 8 EpiCept ... that it has,completed its Phase I clinical trial ... objectives. EPC2407 is EpiCept,s novel small molecule vascular,disruption ... of patients,with advanced solid tumors and lymphomas. ...

... Logix, Inc. today announced the,presentation of positive ... Phase,1 repeat-dose clinical trial of its investigational ... protein (MTP) inhibitor being developed for the ... the bloodstream). The data,indicated not only that ...

Other Medicine Technology:EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407 2 EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407 3 EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407 4 EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407 5 EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407 6 Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism 2 Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism 3

EpiCept Announces Successful Completion of Enrollment for Phase I Trial of EPC2407 Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism

(Date:12/16/2009)... Pen and Paper technology and the provider of the optimal ... it is ranked among the Fastest Growing Technology Companies on ... ... (PRWEB) December 16, 2009 -- ... digitalization and management of handwritten data. Kayentis targets the Healthcare ...

(Date:12/16/2009)... annual marketing campaign , ... Englewood, ... 2010 Genetown™ Hotbed Campaign as its largest yearly promotion ... by MassBio and showcases 37 Massachusetts companies across ... entity’s brand on an electronic and printed map ...

(Date:12/16/2009)... government report finds , , WEDNESDAY, Dec. 16 (HealthDay News) ... 45.4 million Americans of all ages -- or 15.1 ... according to new National Health Interview Survey statistics released ... of all ages had been uninsured for at least ... 31.9 million (10.6 percent) had been uninsured for more ...

(Date:12/16/2009)... FRANCISCO, Dec. 16 Shoppers like knowing ... Mexico or Argentina. But grocers have found it ... Labeling (COOL) laws requiring them to provide the ... website at easyCOOLnow.com for easily making ... laws include provisions that require retailers of unprocessed ...

(Date:12/16/2009)... 16 Medical travel facilitator Companion Global ... Puerto Rico into its network of international hospitals ... than those at mainland U.S. facilities. ,, The ... travel assistance and preferred pricing for its individual ... at either HIMA San Pablo Bayamon or HIMA ...

Breaking Medicine News(10 mins):Health News:With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 2 Health News:Thriving Bioscience Region Leaves Its Mark 2 Health News:Over 45 Million Americans Now Lack Health Insurance 2 Health News:New Website Helps Grocers Comply With COOL Laws 2 Health News:Hospitals in Puerto Rico Join Companion Global Healthcare's Network 2

[0] With a Revenue Growth of Over 500% During the Last 5 Years, Kayentis is Ranked on the Deloitte Technology Fast 500 -- EMEA 2009 [0] Thriving Bioscience Region Leaves Its Mark [1] Over 45 Million Americans Now Lack Health Insurance [1] New Website Helps Grocers Comply With COOL Laws [0] Hospitals in Puerto Rico Join Companion Global Healthcare's Network

... N.Y., Jan. 14 A special series of ... provides a comprehensive look at future directions of ... the scientific understanding of the genetic basis of human skin ... perspectives, are published by Mary Ann Liebert, Inc., ...

... celebration of Inauguration Day, Berry,Chill is offering free Berry ... 20. , The Berry Obama ... topped with blueberries, blue candy-covered almonds, and blue,sprinkles to ... of,patriotism, the special combination will be topped with fresh ...

... Ignagni, President and CEO of America,s Health Insurance ... the U.S. House of Representatives for voting to ... Program (SCHIP): "Today the House voted to ... for essential health care services, including primary care, ...

... Jan. 14 The following fact sheet was released ... House: Divided We Fail Partnership (AARP, Business Roundtable, National ... behalf of Divided We Fail, we urge you to ... Health Insurance Program (SCHIP). Our nation has a duty ...

... Association rapid access journal report:Study highlights:-- The time from ... scene was similar between men and women patients. , ... continued until they were delivered to emergency departments. ... were more likely to be delayed, but other research ...

... Complex Rehab MarketHOUSTON, Jan. 14 Anne Kieschnik, a ... has joined Alliance Seating & Mobility (ASM), ... companies. Kieschnik is an Assistive Technology Professional ... Texas, for ASM ( www.alliance-seating.com ) and is responsible ...

Other Medicine News:Health News:Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race 2 Health News:Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race 3 Health News:Inauguration Day Deal: Get a Free Berry Obama Chilled Yogurt at Berry Chill 2 Health News:Health Care For 11 Million Children 2 Health News:Health Care For 11 Million Children 3 Health News:Health Care For 11 Million Children 4 Health News:Women May Be More Likely to Experience EMS Delays for Heart Care 2 Health News:Women May Be More Likely to Experience EMS Delays for Heart Care 3 Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 2 Health News:Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas 3

Zebrafish Journal Publishes Skin Pigmentation Studies That Shed Light on the Evolution of Race Inauguration Day Deal: Get a Free Berry Obama Chilled Yogurt at Berry Chill AHIP Congratulates House on Passage of SCHIP Health Care For 11 Million Children Women May Be More Likely to Experience EMS Delays for Heart Care Veteran Rehab Specialist, Anne Kieschnik, Joins Fast-Growing Alliance Seating & Mobility In Texas

Increased stent scaffolding at the proximal end gives optimal lumen support and 6F guide catheter compatibility and improved tracking offer excellent deliverability. Customized balloon lengths for ea...

For support, strength and control in your interventions, the RunWay Guide Catheter's large lumen and high-performance design represents a new era in guide catheters....

... Utilizing technology developed over Guidants 20-year history, ... new foundation for successful treatment outcomes. It ... design with a lower profile shaft,more flexible ... you can cross tight and tortuous anatomy ...

Medicine Products:

Express Biliary SD Stent System 90 cm RunWay™ Femoral Curve Left RunWay™ Femoral Left Short Tip Voyager RX Coronary Dilatation Catheter 20 mm

Micromet to Present at The 8th Annual BIO Investor Forum Conference on Octobe...( BETHESDA Md. Oct. 21 /- Micromet Inc....),Health